Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | MEDIORG Medicamen Organics Ltd. Pharma · SME | MONOPHARMA Mono Pharmacare Ltd. Pharma · SME | SUNREST Sunrest Lifescience Ltd. Pharma · SME | SAROJA Saroja Pharma Industries India Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 13 | 20 | 68 | 49 |
| Verdict | OVERVALUED | OVERVALUED | UNDERVALUED | FAIR VALUE |
| Style | Distress Watch | Distress Watch | Deep Value | Deep Value |
| Piotroski | 4/9 | 3/9 | 6/9 | 6/9 |
| Valuation | 5/30 | 16/30 | 29/30 | 30/30 |
| Growth | 10/25 | 10/25 | 24/25 | 15/25 |
| Quality | 0/20 | 0/20 | 14/20 | 0/20 |
| Balance Sheet | 4/15 | 0/15 | 6/15 | 7/15 |
| Cash Flow | 0/10 | 0/10 | 0/10 | 1/10 |
| Price | ₹20 | ₹11.8 | ₹34 | ₹33.95 |
| P/E | — | 25.10 | 7.08 | 8.43 |
| P/B | 0.89 | 0.67 | 1.43 | 0.79 |
| ROE | -13.70% | 10.40% | 22.40% | 9.83% |
| ROCE | -10.70% | 11.00% | 28.60% | 13.00% |
| Debt / Equity | 0.50 | 1.72 | 0.85 | 0.83 |
| FCF Yield | — | — | — | — |
| Dividend Y | — | — | — | — |
| Altman Z | 1.52 | 1.78 | 2.23 | 2.91 |
| Promoter % | 59.73% | 56.72% | 53.50% | 73.02% |
| Mkt Cap (₹Cr) | 25.60 | 20.80 | 29.20 | 13.60 |
| Graham # | — | ₹13.68 | ₹50.7 | ₹62.44 |
| Fair PE | 42.0 | 42.3 | 42.0 | 42.0 |
| MoS % | — | +40.6% | +83.1% | +80.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startMEDIORG15
MONOPHARMA38
SUNREST50
SAROJA86